急性冠脉综合征红细胞胆固醇含量与基质金属蛋白酶-9的相关性
被引量:4
摘要
急性冠脉综合征(acute coronary sydrome,ACS)患者红细胞膜总胆固醇含量(total cholesterol content of erythrocyte membranes,CEM)高于稳定性心绞痛(SAP)患者和健康对照人群,即不同的冠心病临床状态其CEM明显不同。
出处
《中国老年学杂志》
CAS
CSCD
北大核心
2012年第4期799-801,共3页
Chinese Journal of Gerontology
参考文献11
-
1Tziakas DN,Kaski JC.Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome:a new marker of clinical instability[J]? J Am Coll Cardiol,2007 ;49:2081-9.
-
2Kolodgie FD,Herman KCB,Burke AP,et al.Intraplaque hemorrhage and progression of coronary atheroma[J].N Engl J Med,2003 ;349:2316-25.
-
3Moreno PR,Purushothaman KR,Fuster V,et al.Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta.Implications for plaque vulnerability[J].Circulation,2004 ; 110 (14):20.-8.
-
4Kolodgie FD,Burke AP,Nakazawa G,et al.Free cholesterol in atherosclerotic plaques:where does it come from[J]? Curr Opin Lipidol,2007;18(5):500-7.
-
5Bea F,Blessing E,Bennett B.Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering[J].Arterioscler Thromb Vasc Biol,2002 ;22:18..
-
6Jones CB,Sane DC,Herrington DM.Matrix metalloproteinases:a review of their structure and role in acute coronary syndrome[J].Cardiovasc Res,2003 ;59(4):812-23.
-
7刘启明,周胜华,祁述善,沈向前,胡信群,刘振江.急性冠状动脉综合征患者冠状动脉循环中基质金属蛋白酶-9和白细胞介素-18变化及其意义[J].中国循环杂志,2003,18(4):253-255. 被引量:3
-
8Nomoto K,Oguchi S,Watanabe I,et al.Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein,matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1[J].J Cardiol,2003 ;42(5):201-6.
-
9Zeng B,Prasan A,Fung KC,et al.Elevated circulating levels of matrix metalloproteinase-9 and-2 in patients with symptomatic coronary artery disease[J].Intern Med J,2005;35(6):331-5.
-
10Blankenberg S,Rupprecht HJ,Poirier O,et al.Plasma concentrations and genetic variation of matrix metalloproteinase-9 and prognosis of patients with cardiovascular disease[J].Circulation,2003 ; 107 (12):1579-85.
二级参考文献10
-
1Vidal-vanaclocha F, Fantuzzi G, Mendoza L, et al. IL-18 regulates IL-1 beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci, 2000, 97: 734-739.
-
2Mallat Z, Corbaz A, Scoazee A, et al. Expression of Interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation,2001, 104: 1598-1603.
-
3Lee TS, Yen HC, Pan CC, et al. The role of interleukin 12 in the development of atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vasc Biol, 1999, 19: 734-742.
-
4Fantuzzi G, Reed DA, Dinareno CA. I1-12 induced IFN-ganuna is dependent on easpase-1 processing of the IL-18 precursor. J Clin Invest, 1999,104: 761-767.
-
5Mallat Z, Corbaz A, Scoazee A, et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotie lesion development and stability. Cire Res, 2001, 89: E41-E45.
-
6Seta Y, Kanda T, Tanaka T, et al. Interleukin 18 in acute myocardial infarction. Heart, 2000, 84: 668.
-
7Kaartinen M, Van der Wal AC, Van der Loos CM, et al. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Call Cardiol, 1998, 32: 606-612.
-
8Maisel A, Cesario D, Baird S, et al. Experimental autoimmune myocardio tis produced by adoptive transfer of splenocytes after myocardial infarction.Circ Res, 1998, 82: 458-463.
-
9Inokubo Y, Hanada H, Ishizaka H, et al. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J,2001, 141: 211-217.
-
10Haroon ZA, Wannenburg T, Gupta M, et al. Localization of tissue trans glutaminase in human carotid and coronary artery atherosclerosis: implica tions for plaque stability and progression. Lab Invest, 2001, 81 : 83-93.
同被引文献51
-
1张建华,徐岩,陈旭华,伍梦佐,程自平,陈斌.红细胞膜总胆固醇含量与急性冠状动脉综合征的相关性研究[J].中华临床医师杂志(电子版),2011,5(11):3164-3169. 被引量:4
-
2周滔,杨德光,陈小芳,肖孟,潜学勤.红细胞膜胆固醇水平与非ST抬高型急性冠状动脉综合征患者PCI相关冠状动脉慢血流或无复流发生相关[J].中国动脉硬化杂志,2015,23(4):379-383. 被引量:11
-
3周宪梁,孙凯,李昭晖,孙莉,邹玉宝,惠汝太.基质金属蛋白酶与动脉粥样硬化斑块发生、发展的关系[J].中国比较医学杂志,2006,16(12):705-709. 被引量:11
-
4Johnson JL.Matrix metalloproteinases:influence on smooth muscle cells and atherosclerotic plaque stability[J].Expert Rev Cardiovasc Ther,2007;5(2):265-82.
-
5Back M,Ketelhuth DF,Agewall S.Matrix metalbproteinases in atherothrombosis[J].Prog Cardiovasc Dis,2010;52(5):410-28.
-
6Shiomi M,Ho T,Hirouchi Y,et al.Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins[J].Atherosclerosis,2001;157(1):75-84.
-
7van Bussel BC,Schouten F,Henry RM,et al.Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period[J].Hypertension,2011;58(4):588-95.
-
8PENNY W F, BEN-YEHUDA O, KUROE K, et al. Improvement of coronary artery endothelial dysfunetion with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein [J]. J Am Coll Cardiol, 2001, 37(3): 766-774.
-
9ARBUSTINI E, MORBINI P, D'ARMINI A M, et al. Plaque eomposition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation[J]. Heart, 2002, 88(2): 177-182.
-
10KOLODGIE F D, GOLD H K, BURKE A P, et al. Intraplaque hemorrhage and progression of coronary atheroma [ J ]. New Eng J Med, 2003, 349(24): 2316-2325.
引证文献4
-
1王海英.心血管风险标志物的检测及进展[J].中国医药导刊,2014,16(1):167-168. 被引量:1
-
2肖宪杰,纪焕春.冠状动脉粥样硬化性心脏病患者血清MMP-2、-9及IL-6水平及意义[J].中国老年学杂志,2014,34(22):6314-6315. 被引量:15
-
3严俊儒,刘洁香,刘宝骅,李素颀,胡蛟龙.红细胞膜总胆固醇与人血浆脂蛋白磷脂酶A2与冠心病的关系[J].岭南心血管病杂志,2015,21(2):172-175.
-
4吕慧清,田刚,张华,徐福胜.红细胞膜总胆固醇联合Gensini评分对经皮冠状动脉介入术后急性冠脉综合征患者近期预后的评估价值研究[J].实用心脑肺血管病杂志,2021,29(6):46-50. 被引量:10
二级引证文献26
-
1徐荣建,苗齐,刘兴荣,张超纪,马国涛,曹丽华,刘剑州,黄卓,李晓凤.体外循环心脏手术后胸腔积液发生率及危险因素分析[J].中国心血管病研究,2014,12(6):481-484. 被引量:4
-
2谢雪姣,李亚梅,徐佳,廖端芳,吴若霞,尹栋梁,陈聪伶.加味二陈汤对ApoE^(-/-)小鼠炎症标志物IL-6和TNF-α的调节作用[J].中南医学科学杂志,2015,43(6):605-609. 被引量:3
-
3潘娅萍.87例绝经期前女性冠状动脉粥样硬化性心脏病病人临床资料分析[J].中西医结合心脑血管病杂志,2016,14(5):461-463.
-
4尹成淑,孟晓萍,曹振东,宗春光,王璐,赵翠,张孔雁.丹红注射液对不稳定型心绞痛患者血清中MMPs、CK-MB和OX-LDL的影响[J].中国医院药学杂志,2016,36(8):650-653. 被引量:11
-
5朱于坚.MMP-2、MMP-3、MMP-10及TIMP-1与1型糖尿病蛋白尿的相关性研究[J].临床和实验医学杂志,2016,15(12):1154-1158. 被引量:3
-
6石红玲,史雪霞,马秀莲,任明.依达拉奉联合前列地尔治疗不稳定型心绞痛的临床观察[J].中国药房,2016,27(26):3687-3689. 被引量:13
-
7左宝功,宋春丽,党岩兵,闫业军.瑞舒伐他汀对急性心肌梗死患者MMPs及炎症因子的影响[J].中国热带医学,2016,16(10):1032-1035. 被引量:1
-
8乔智力,高凤敏,徐彪,杨骄霞.注射用血塞通对PCI术后急性心肌梗死病人炎症因子、基质金属蛋白酶的影响[J].中西医结合心脑血管病杂志,2016,14(20):2394-2396. 被引量:13
-
9郑俊晨,李林娟,高波,王营忠.麝香保心丸对冠心病患者MMP-2、MMP-9表达的影响[J].河南中医,2017,37(1):74-76. 被引量:2
-
10周慧飞,邹静.辛伐他汀强化降脂治疗对急性心肌梗死患者血清hs-CRP、TNF-α、IL-6、MMP-9、MMP-2的影响[J].中国生化药物杂志,2017,37(4):317-319. 被引量:5
-
1丁建平,丁蔚,郜峰.肝病患者红细胞膜胆固醇的测定及其临床意义[J].陕西医学检验,1994,9(1):43-44. 被引量:3
-
2孙志军,陈晖,李虹伟.红细胞膜总胆固醇含量——急性冠状动脉综合征的一个新型标志物[J].心血管病学进展,2009,30(3):453-455. 被引量:4
-
3徐亚英,童文祥.肝病患者红细胞膜胆固醇的测定及其临床意义[J].江苏临床医学杂志,2000,4(6):479-479.
-
4朱秀英,姜礼红,鲍莉莉.心脑血管病患者红细胞膜胆固醇的测定研究[J].哈尔滨医科大学学报,2002,36(6):468-469. 被引量:1
-
5段静思,张建华,徐岩.急性冠状动脉综合征标志物预测价值的新进展[J].心血管病学进展,2011,32(6):806-808. 被引量:4
-
6谭金山,侯颖,刘成玉,王秀丽.非胰岛素依赖型糖尿病病人红细胞形态变化及其影响因素的观察[J].青岛医学院学报,1996,32(4):321-323. 被引量:1
-
7余梅玫,徐岩.红细胞膜总胆固醇含量与急性冠状动脉综合征的相关性[J].临床心血管病杂志,2012,28(7):492-495. 被引量:4
-
8刘哲,张素华,张利宣,齐丽娟.老年急性冠状动脉综合征患者红细胞膜总胆固醇含量临床意义分析[J].河北医药,2012,34(4):578-578. 被引量:1
-
9张卫光,潘文萧,沈芳,田珑,夏家骝,严宗毅,文宗曜.大鼠肝硬化形成早期的红细胞电泳率和红细胞膜胆固醇含量改变的研究[J].解剖科学进展,2004,10(B08):20-21.
-
10余梅玫(综述),徐岩(,审校).红细胞膜脂质与急性冠脉综合征发病机制的相关研究[J].心脏杂志,2009(3):426-428. 被引量:1